Proteostasis imbalance: Unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies
Advances in Protein Chemistry and Structural Biology · 2025
DOI: 10.1016/bs.apcsb.2024.11.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2025. Verfasst von Chandrabose Selvaraj und 3 weiteren Autor:innen. Beteiligte Einrichtung: CsrDD Lab, Bioinformatics Division, Department of Marine Biotechnology, AMET University, East Coast Road, Kanathur, Chennai, India. Electronic addres…. Hauptthemen laut MEDLINE: Proteostasis, Neurodegenerative Diseases, Protein Aggregation, Pathological, Protein Aggregates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and ALS are defined by the accumulation of misfolded and aggregated proteins, which impair cellular function and result in progressive neuronal death. This chapter examines the critical function of proteostasis-cellular protein homeostasis-in sustaining neuronal health and its disruption as a key factor in disease progression. Proteostasis is upheld by a complex array of mechanisms, which encompass molecular chaperones, the ubiquitin-proteasome system, autophagy-lysosomal pathways, and mitochondrial quality control. Impairment of these systems leads to protein misfolding and aggregation, resulting in toxic cellular environments that promote neurodegeneration. Novel therapeutic approaches focus on restoring proteostasis through the enhancement of cellular protein folding, degradation, and clearance mechanisms. This encompasses small molecule chaperones, gene therapy, RNA-based treatments, immunotherapy, autophagy inducers, and stem cell-based approaches, each addressing distinct components of the proteostasis network to mitigate or prevent disease progression. While these therapies show potential, challenges persist, such as possible side effects, selective targeting, and the efficacy of blood-brain barrier penetration. Personalized medicine and combination therapies customized to specific disease profiles are increasingly recognized for their potential to improve efficacy and safety. This chapter consolidates recent developments in therapies aimed at proteostasis, addresses the challenges encountered in clinical applications, and outlines potential future directions for transformative treatments. Ongoing research indicates that proteostasis modulation may significantly alter the course of neurodegenerative disease treatment, potentially enhancing patient outcomes and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CsrDD Lab, Bioinformatics Division, Department of Marine Biotechnology, AMET University, East Coast Road, Kanathur, Chennai, India. Electronic address: selva@csrdd.org.
- Department of Biotechnology and Bioinformatics, Holy Cross College, Tiruchirappalli, Tamil Nadu, India.
- Department of Microbiology, Dr. D. Y. Patil Medical College Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, India.
- Electric Power Research Institute, 1300 W W T Harris Blvd, Charlotte, NC, United States.
Zitieren
APA
Selvaraj, C., Vijayalakshmi, P., Desai, D., & Manoharan, J. (2025). Proteostasis imbalance: Unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2024.11.008
Vancouver
Selvaraj C, Vijayalakshmi P, Desai D, Manoharan J. Proteostasis imbalance: Unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies. Advances in Protein Chemistry and Structural Biology. 2025. doi:10.1016/bs.apcsb.2024.11.008
BibTeX
@article{Selvaraj2025,
author = {Selvaraj, Chandrabose and Vijayalakshmi, Periyasamy and Desai, Dipali and Manoharan, Jayakumar},
title = {Proteostasis imbalance: Unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies},
journal = {Advances in Protein Chemistry and Structural Biology},
year = {2025},
doi = {10.1016/bs.apcsb.2024.11.008}
}
EUVIMED